HUTCHMED Announces Updated Board Composition and Committee Assignments

Bulletin Express05-13 16:46

HUTCHMED (China) Limited released an updated breakdown of its nine-member Board of Directors and their respective committee roles as of 13 May 2026.

The Board remains chaired by Non-executive Director Dr Dan Eldar. Executive responsibilities continue under Dr Weiguo Su, listed as Chief Executive Officer* and Chief Scientific Officer, and Mr Cheng Chig Fung, Johnny, who serves as Acting Chief Executive Officer and Chief Financial Officer.

Non-executive Directors comprise Ms Edith Shih and Ms Ling Yang, while Independent Non-executive Directors include Dr Renu Bhatia (also appointed Senior and Lead INED), Dr Chaohong Hu, Professor Tan Shao Weng, Daniel, and Mr Wong Tak Wai.

Committee leadership highlights: • Audit Committee – Chaired by Mr Wong Tak Wai, with Dr Renu Bhatia and Dr Chaohong Hu as members. • Nomination Committee – Chaired by Dr Renu Bhatia; Dr Chaohong Hu also serves as a member. • Remuneration Committee – Chaired by Dr Renu Bhatia, joined by Ms Edith Shih and Mr Wong Tak Wai. • Sustainability Committee – Chaired by Ms Edith Shih, with Mr Cheng Chig Fung, Johnny and Professor Tan Shao Weng, Daniel acting as members. • Technical Committee – Chaired by Dr Chaohong Hu, with Dr Renu Bhatia, Professor Tan Shao Weng, Daniel and Dr Weiguo Su as members; Dr Dan Eldar participates as a committee member.

HUTCHMED underscores continuity in leadership while delineating clear oversight across audit, nomination, remuneration, sustainability and technical domains. *Dr Su is currently on leave from his CEO duties.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1189258942?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-13 16:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1189258942","market":"us","top_or_hot":-1,"title":"HUTCHMED Announces Updated Board Composition and Committee Assignments","media":"Bulletin Express","content":"<p>HUTCHMED (China) Limited released an updated breakdown of its nine-member Board of Directors and their respective committee roles as of 13 May 2026.</p>\n<p>The Board remains chaired by Non-executive Director Dr Dan Eldar. Executive responsibilities continue under Dr Weiguo Su, listed as Chief Executive Officer* and Chief Scientific Officer, and Mr Cheng Chig Fung, Johnny, who serves as Acting Chief Executive Officer and Chief Financial Officer.</p>\n<p>Non-executive Directors comprise Ms Edith Shih and Ms Ling Yang, while Independent Non-executive Directors include Dr Renu Bhatia (also appointed Senior and Lead INED), Dr Chaohong Hu, Professor Tan Shao Weng, Daniel, and Mr Wong Tak Wai.</p>\n<p>Committee leadership highlights:\n• Audit Committee – Chaired by Mr Wong Tak Wai, with Dr Renu Bhatia and Dr Chaohong Hu as members.  \n• Nomination Committee – Chaired by Dr Renu Bhatia; Dr Chaohong Hu also serves as a member.  \n• Remuneration Committee – Chaired by Dr Renu Bhatia, joined by Ms Edith Shih and Mr Wong Tak Wai.  \n• Sustainability Committee – Chaired by Ms Edith Shih, with Mr Cheng Chig Fung, Johnny and Professor Tan Shao Weng, Daniel acting as members.  \n• Technical Committee – Chaired by Dr Chaohong Hu, with Dr Renu Bhatia, Professor Tan Shao Weng, Daniel and Dr Weiguo Su as members; Dr Dan Eldar participates as a committee member.</p>\n<p>HUTCHMED underscores continuity in leadership while delineating clear oversight across audit, nomination, remuneration, sustainability and technical domains. *Dr Su is currently on leave from his CEO duties.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HUTCHMED Announces Updated Board Composition and Committee Assignments</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHUTCHMED Announces Updated Board Composition and Committee Assignments\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-13 16:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>HUTCHMED (China) Limited released an updated breakdown of its nine-member Board of Directors and their respective committee roles as of 13 May 2026.</p>\n<p>The Board remains chaired by Non-executive Director Dr Dan Eldar. Executive responsibilities continue under Dr Weiguo Su, listed as Chief Executive Officer* and Chief Scientific Officer, and Mr Cheng Chig Fung, Johnny, who serves as Acting Chief Executive Officer and Chief Financial Officer.</p>\n<p>Non-executive Directors comprise Ms Edith Shih and Ms Ling Yang, while Independent Non-executive Directors include Dr Renu Bhatia (also appointed Senior and Lead INED), Dr Chaohong Hu, Professor Tan Shao Weng, Daniel, and Mr Wong Tak Wai.</p>\n<p>Committee leadership highlights:\n• Audit Committee – Chaired by Mr Wong Tak Wai, with Dr Renu Bhatia and Dr Chaohong Hu as members.  \n• Nomination Committee – Chaired by Dr Renu Bhatia; Dr Chaohong Hu also serves as a member.  \n• Remuneration Committee – Chaired by Dr Renu Bhatia, joined by Ms Edith Shih and Mr Wong Tak Wai.  \n• Sustainability Committee – Chaired by Ms Edith Shih, with Mr Cheng Chig Fung, Johnny and Professor Tan Shao Weng, Daniel acting as members.  \n• Technical Committee – Chaired by Dr Chaohong Hu, with Dr Renu Bhatia, Professor Tan Shao Weng, Daniel and Dr Weiguo Su as members; Dr Dan Eldar participates as a committee member.</p>\n<p>HUTCHMED underscores continuity in leadership while delineating clear oversight across audit, nomination, remuneration, sustainability and technical domains. *Dr Su is currently on leave from his CEO duties.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00013","symbol_name":"和黄医药","start_time":0,"source_url":"","article_id":"1189258942","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1189258942","pubTimestamp":1778661981,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"HUTCHMED (China) Limited released an updated breakdown of its nine-member Board of Directors and their respective committee roles as of 13 May 2026. The Board remains chaired by Non-executive...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00013":"和黄医药"},"translate_title":"和黄医药宣布更新董事会组成和委员会任务","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00013":1},"content_text":"HUTCHMED (China) Limited released an updated breakdown of its nine-member Board of Directors and their respective committee roles as of 13 May 2026.\nThe Board remains chaired by Non-executive Director Dr Dan Eldar. Executive responsibilities continue under Dr Weiguo Su, listed as Chief Executive Officer* and Chief Scientific Officer, and Mr Cheng Chig Fung, Johnny, who serves as Acting Chief Executive Officer and Chief Financial Officer.\nNon-executive Directors comprise Ms Edith Shih and Ms Ling Yang, while Independent Non-executive Directors include Dr Renu Bhatia (also appointed Senior and Lead INED), Dr Chaohong Hu, Professor Tan Shao Weng, Daniel, and Mr Wong Tak Wai.\nCommittee leadership highlights:\n• Audit Committee – Chaired by Mr Wong Tak Wai, with Dr Renu Bhatia and Dr Chaohong Hu as members.  \n• Nomination Committee – Chaired by Dr Renu Bhatia; Dr Chaohong Hu also serves as a member.  \n• Remuneration Committee – Chaired by Dr Renu Bhatia, joined by Ms Edith Shih and Mr Wong Tak Wai.  \n• Sustainability Committee – Chaired by Ms Edith Shih, with Mr Cheng Chig Fung, Johnny and Professor Tan Shao Weng, Daniel acting as members.  \n• Technical Committee – Chaired by Dr Chaohong Hu, with Dr Renu Bhatia, Professor Tan Shao Weng, Daniel and Dr Weiguo Su as members; Dr Dan Eldar participates as a committee member.\nHUTCHMED underscores continuity in leadership while delineating clear oversight across audit, nomination, remuneration, sustainability and technical domains. *Dr Su is currently on leave from his CEO duties.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"executive,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1189258942","isCrawlerRequest":true}